International cohort study indicates no association between alpha-1 blockers and susceptibility to COVID-19 in benign prostatic hyperplasia patients

Purpose: Alpha-1 blockers, often used to treat benign prostatic hyperplasia (BPH), have been hypothesized to prevent COVID-19 complications by minimising cytokine storm release. The proposed treatment based on this hypothesis currently lacks support from reliable real-world evidence, however. We lev...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Akihiko Nishimura, Junqing Xie, Kristin Kostka, Talita Duarte-Salles, Sergio Fernández Bertolín, María Aragón, Clair Blacketer, Azza Shoaibi, Scott L. DuVall, Kristine Lynch, Michael E. Matheny, Thomas Falconer, Daniel R. Morales, Mitchell M. Conover, Seng Chan You, Nicole Pratt, James Weaver, Anthony G. Sena, Martijn J. Schuemie, Jenna Reps, Christian Reich, Peter R. Rijnbeek, Patrick B. Ryan, George Hripcsak, Daniel Prieto-Alhambra, Marc A. Suchard
Format:	Artigo
Sprog:	Inglês
Udgivet:	Frontiers Media S.A. 2022-09-01
Serier:	Frontiers in Pharmacology
Fag:	treatment for SARS CoV-2 observational study electronic health records federated data model causal inference open science
Online adgang:	https://www.frontiersin.org/articles/10.3389/fphar.2022.945592/full
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!